Literature DB >> 12871635

Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments.

Bennett D Elzey1, Jun Tian, Robert J Jensen, Axel K Swanson, Jason R Lees, Steven R Lentz, Colleen S Stein, Bernhard Nieswandt, Yiqiang Wang, Beverly L Davidson, Timothy L Ratliff.   

Abstract

Platelets are highly reactive components of the circulatory system with well-documented hemostatic function. Recent studies extend platelet function to modulation of local inflammatory events through the release of chemokines, cytokines, and a number of immunomodulatory ligands, including CD154. We hypothesized that platelet-derived CD154 modulates adaptive immunity. The data reported herein demonstrate that platelets, via CD154, induce dendritic cell maturation, B cell isotype switching, and augment CD8(+) T cell responses both in vitro and in vivo. Platelet transfusion studies demonstrate that platelet-derived CD154 alone is sufficient to induce isotype switching and augment T lymphocyte function during viral infection, leading to enhanced protection against viral rechallenge. Additionally, depletion of platelets in normal mice results in decreased antigen-specific antibody production.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12871635     DOI: 10.1016/s1074-7613(03)00177-8

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  114 in total

1.  Internalization of IgG-coated targets results in activation and secretion of soluble CD40 ligand and RANTES by human platelets.

Authors:  Adam J Antczak; Joshua A Vieth; Navinderjit Singh; Randall G Worth
Journal:  Clin Vaccine Immunol       Date:  2010-12-22

Review 2.  Platelet CD40L at the interface of adaptive immunity.

Authors:  Bennett D Elzey; Timothy L Ratliff; Jennifer M Sowa; Scott A Crist
Journal:  Thromb Res       Date:  2010-11-13       Impact factor: 3.944

Review 3.  Platelet-leukocyte interactions in cardiovascular disease and beyond.

Authors:  Licia Totani; Virgilio Evangelista
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-11       Impact factor: 8.311

Review 4.  Platelets in the pathogenesis of acute respiratory distress syndrome.

Authors:  Hemang Yadav; Daryl J Kor
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-08-28       Impact factor: 5.464

5.  Lipopolysaccharide induces sCD40L release through human platelets TLR4, but not TLR2 and TLR9.

Authors:  Fabrice Cognasse; Sandrine Lafarge; Patricia Chavarin; Sophie Acquart; Olivier Garraud
Journal:  Intensive Care Med       Date:  2006-12-19       Impact factor: 17.440

Review 6.  New Insights on Platelets and Platelet-Derived Microparticles in Systemic Lupus Erythematosus.

Authors:  Marc Scherlinger; Vanja Sisirak; Christophe Richez; Estibaliz Lazaro; Pierre Duffau; Patrick Blanco
Journal:  Curr Rheumatol Rep       Date:  2017-08       Impact factor: 4.592

Review 7.  The role of platelet CD154 in the modulation in adaptive immunity.

Authors:  Daniel L Sprague; Jennifer M Sowa; Bennett D Elzey; Timothy L Ratliff
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

8.  Platelet-derived or soluble CD154 induces vascularized allograft rejection independent of cell-bound CD154.

Authors:  He Xu; Xiaojie Zhang; Roslyn B Mannon; Allan D Kirk
Journal:  J Clin Invest       Date:  2006-02-23       Impact factor: 14.808

Review 9.  Cancer prevention by aspirin in children with Constitutional Mismatch Repair Deficiency (CMMRD).

Authors:  Erika K S M Leenders; Harm Westdorp; Roger J Brüggemann; Jan Loeffen; Christian Kratz; John Burn; Nicoline Hoogerbrugge; Marjolijn C J Jongmans
Journal:  Eur J Hum Genet       Date:  2018-06-14       Impact factor: 4.246

10.  Platelet-derived hyaluronidase 2 cleaves hyaluronan into fragments that trigger monocyte-mediated production of proinflammatory cytokines.

Authors:  Carol de la Motte; Julie Nigro; Amit Vasanji; Hyunjin Rho; Sean Kessler; Sudip Bandyopadhyay; Silvio Danese; Claudio Fiocchi; Robert Stern
Journal:  Am J Pathol       Date:  2009-05-14       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.